Skip to main content
. Author manuscript; available in PMC: 2021 Nov 4.
Published in final edited form as: Obesity (Silver Spring). 2021 Jun;29(6):1036–1045. doi: 10.1002/oby.23160

Table 1.

Cord Blood Adipocytokine Concentrations, Whole Body Fat Mass Index, and Cardiometabolic Risk Scores at Age 12 Years According to Covariates among Children from the Health Outcomes and Measures of the Environment (HOME) Study (N=166).

N Leptin (ng/mL) N Adiponectin
(μg/mL)
N Adiponectin-
to-Leptin Ratio
N Whole Body
Fat Mass Index
N Novel CM
Risk Score
Overall 159 10 (6, 16) 166 42 (30, 51) 159 4.3 (2.4, 7.1) 158 6.3 (4.7, 8.1) 135 0.1 (2.7)
Child Sex
 Female 87 12 (8, 20) 93 42 (33, 51) 87 3.2 (2.1, 5.6) 89 6.5 (5.3, 8.6) 74 0.0 (2.8)
 Male 72 7 (3, 12) 73 41 (27, 51) 72 5.5 (3.2, 9.5) 69 5.4 (4.4, 7.3) 61 0.2 (2.6)
Child Race
 Non-Hispanic White 99 11 (6, 17) 104 44 (34, 53) 99 4.5 (2.3, 6.9) 99 6.3 (5.0, 7.7) 84 −0.1 (2.8)
 Non-Hispanic Black 50 9 (7, 15) 51 36 (26, 50) 50 3.4 (2.4, 6.5) 49 6.3 (4.7, 8.8) 41 0.6 (2.7)
 Other 10 5 (1, 8) 11 39 (20, 49) 10 7.6 (3.3,14) 10 5.2 (3.8, 8.0) 10 −0.4 (1.8)
Breastfeeding Duration
 0 month 27 9 (4, 15) 29 34 (22, 47) 27 4.3 (2.4, 8.3) 28 6.6 (4.7,11) 22 1.4 (2.8)
 >0-6 months 67 10 (6, 16) 68 45 (35, 55) 67 4.9 (2.5, 8.2) 64 5.9 (4.6, 7.3) 58 −0.4 (2.4)
 >6 months 65 10 (6, 17) 69 41 (30, 50) 65 4.0 (2.1, 6.5) 66 6.5 (5.0, 8.4) 55 0.1 (2.9)
Maternal Age
 18-25 Years 35 7 (4, 12) 35 39 (26, 47) 35 5.4 (3.3, 8.6) 33 5.4 (4.5, 8.3) 28 −0.2 (2.2)
 >25-35 Years 103 12 (7, 17) 108 43 (33, 53) 103 3.6 (2.3, 6.8) 103 6.4 (5.0, 8.1) 87 0.1 (2.8)
 >35 Years 21 8 (7, 12) 23 45 (22, 53) 21 5.4 (2.6, 7.1) 22 5.4 (4.7, 8.0) 20 0.4 (3.3)
Maternal Education
 High School or Less 29 8 (5, 15) 30 38 (22, 55) 29 5.4 (2.4, 7.4) 28 7.1 (5.0, 9.7) 22 1.1 (3.0)
 Tech School or Some College 45 10 (7, 17) 48 41 (30, 48) 45 3.3 (2.1, 6.8) 46 6.0 (4.5, 7.8) 42 −0.3 (2.6)
 Bachelor's or More 85 11 (6, 15) 88 44 (33, 53) 85 4.9 (2.9, 6.9) 84 6.3 (5.0, 7.8) 71 0.0 (2.7)
Pre-Pregnancy BMI
 <25 86 8 (4, 13) 90 42 (33, 50) 86 5.4 (3.2, 8.9) 84 5.4 (4.6, 7.2) 69 −0.2 (2.6)
 ≥25-30 39 12 (7, 17) 39 44 (35, 55) 39 3.4 (2.0, 6.8) 39 6.5 (5.2, 8.6) 37 0.0 (2.7)
 ≥30 34 11 (7, 21) 37 41 (24, 53) 34 2.9 (2.1, 4.3) 35 7.4 (5.8,10) 29 1.0 (2.9)
Gestational Serum Cotinine Concentrations (ng/ml)
 <0.015 (Unexposed) 53 11 (4, 15) 56 42 (35, 52) 53 4.9 (2.5, 8.3) 52 6.4 (5.3, 8.2) 43 −0.1 (2.6)
 0.015-3 (Secondhand) 91 10 (7, 16) 93 43 (30, 51) 91 4.3 (2.5, 6.5) 89 6.0 (4.7, 8.0) 80 0.1 (2.8)
 >3 (Active Smoker) 15 7 (4, 17) 17 33 (22, 59) 15 3.0 (2.2, 12) 17 6.3 (4.4, 8.6) 12 1.0 (2.5)
Parity
 0 66 10 (6, 15) 70 44 (34, 51) 66 4.9 (2.5, 6.9) 67 6.3 (5.1, 8.1) 56 −0.3 (2.6)
 1 55 8 (5, 15) 58 43 (33, 52) 55 5.1 (3.1, 8.0) 54 5.8 (4.6, 8.1) 44 0.5 (2.9)
 ≥2 38 11 (7, 20) 38 34 (20, 50) 38 2.7 (1.4, 7.1) 37 6.3 (4.9, 8.3) 35 0.2 (2.6)

All values expressed as Median (25th, 75th); except the CM Risk score, which is expressed as mean (SD)

BMI: body mass index; CM: cardiometabolic; SD: standard deviation; Whole body fat mass index (kg/m2) was calculated as whole body fat mass/ (height*height); Novel CM risk score was the sum of the standardized z-scores for Homeostatic Model Assessment of Insulin Resistance, triglyceride to HDL ratio, systolic blood pressure, and visceral fat area.